-
Something wrong with this record ?
Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia
P. Májek, Z. Reicheltová, J. Suttnar, J. Cermák, JE. Dyr,
Language English Country England, Great Britain
Document type Journal Article
Grant support
NS10633
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
BioMedCentral
from 2003-12-01
BioMedCentral Open Access
from 2003
Directory of Open Access Journals
from 2003
Free Medical Journals
from 2003
PubMed Central
from 2003
Europe PubMed Central
from 2003
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2003-01-01
Open Access Digital Library
from 2003-01-01
Open Access Digital Library
from 2003-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2003
Springer Nature OA/Free Journals
from 2003-12-01
- Publication type
- Journal Article MeSH
BACKGROUND: Refractory cytopenia with multilineage dysplasia (RCMD) is a subgroup of myelodysplastic syndrome (MDS), which belongs to oncohematological diseases, occurring particularly in elderly patients, and represents a heterogeneous group of bone marrow diseases. The goal of this study was to look for plasma proteins that changed quantitatively or qualitatively in RCMD patients. RESULTS: A total of 46 plasma samples were depleted, proteins were separated by 2D SDS-PAGE (pI 4-7), and proteomes were compared using Progenesis SameSpots statistical software. Proteins were identified by nanoLC-MS/MS. Sixty-one unique, significantly (p < 0.05, ANOVA) different spots were found; proteins in 59 spots were successfully identified and corresponded to 57 different proteins. Protein fragmentation was observed in several proteins: complement C4-A, complement C4-B, inter-alpha-trypsin inhibitor heavy chain H4, and endorepellin. CONCLUSIONS: This study describes proteins, which change quantitatively or qualitatively in RCMD patients, and represents the first report on significant alterations in C4-A and C4-B complement proteins and ITIH4 fragments in patients with MDS-RCMD.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13015801
- 003
- CZ-PrNML
- 005
- 20200930105041.0
- 007
- ta
- 008
- 130424s2011 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/1477-5956-9-64 $2 doi
- 035 __
- $a (PubMed)21975265
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Májek, Pavel $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic. pavel.majek@uhkt.cz. $7 xx0128730
- 245 10
- $a Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia / $c P. Májek, Z. Reicheltová, J. Suttnar, J. Cermák, JE. Dyr,
- 520 9_
- $a BACKGROUND: Refractory cytopenia with multilineage dysplasia (RCMD) is a subgroup of myelodysplastic syndrome (MDS), which belongs to oncohematological diseases, occurring particularly in elderly patients, and represents a heterogeneous group of bone marrow diseases. The goal of this study was to look for plasma proteins that changed quantitatively or qualitatively in RCMD patients. RESULTS: A total of 46 plasma samples were depleted, proteins were separated by 2D SDS-PAGE (pI 4-7), and proteomes were compared using Progenesis SameSpots statistical software. Proteins were identified by nanoLC-MS/MS. Sixty-one unique, significantly (p < 0.05, ANOVA) different spots were found; proteins in 59 spots were successfully identified and corresponded to 57 different proteins. Protein fragmentation was observed in several proteins: complement C4-A, complement C4-B, inter-alpha-trypsin inhibitor heavy chain H4, and endorepellin. CONCLUSIONS: This study describes proteins, which change quantitatively or qualitatively in RCMD patients, and represents the first report on significant alterations in C4-A and C4-B complement proteins and ITIH4 fragments in patients with MDS-RCMD.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Riedelová, Zuzana $7 xx0126185
- 700 1_
- $a Suttnar, Jiří, $d 1949- $7 xx0061396
- 700 1_
- $a Čermák, Jaroslav, $d 1954- $7 xx0053072
- 700 1_
- $a Dyr, Jan Evangelista, $u - $d 1946-2021 $7 xx0060262
- 773 0_
- $w MED00008250 $t Proteome science $x 1477-5956 $g Roč. 9(2011), s. 64
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21975265 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130424 $b ABA008
- 991 __
- $a 20200930105038 $b ABA008
- 999 __
- $a ind $b bmc $g 979002 $s 814122
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 9 $d 64 $i 1477-5956 $m Proteome science $n Proteome Sci $x MED00008250
- GRA __
- $a NS10633 $p MZ0
- LZP __
- $a Pubmed-20130424